Clinical trial
CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing
NCT00354757 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00354757 |
|---|---|
| Title | CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing |
| Official title | The Influence of CYP2C19 Genetic Polymorphism and Dosage of Rabeprazole on the Accuracy of Proton-Pump Inhibitor Testing in Chinese Patients With Gastroesophageal Reflux Disease |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | rabeprazole |
| Enrollment | 200 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 20, 2006 |
| Last update posted | Dec 3, 2012 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: